Articles From: Elephant Talk Reports Third Quarter Financial Results to Ellie Mae Achieves Major Milestone with 100,000 Active Encompass Users


2014/11/18
- Company Enters into $12 Million Debt Facility Agreement - OKLAHOMA CITY , Nov.
Sign-up for Elephant Talk Reports Third Quarter Financial Results investment picks
Eleven Biotherapeutics, Inc. (Nasdaq: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced top-line results from a Phase 2 study of its lead drug candidate, EBI-005, in patients with moderate to severe allergic conjunctivitis.
Sign-up for Eleven Biotherapeutics Announces Top-Line Results from Phase 2 Study of EBI-005 in Patients with Moderate to Severe Allergic Conjunctivitis investment picks
2014/10/23
Eleven Biotherapeutics, a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced the appointment of industry veteran Wendy L.
Sign-up for Eleven Biotherapeutics Appoints Wendy L. Dixon, PhD to Board of Directors investment picks
Eleven Biotherapeutics (NASDAQ:EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced the completion of patient enrollment in its first pivotal, Phase 3 clinical study of EBI-005 in patients with dry eye disease.
Sign-up for Eleven Biotherapeutics Completes Enrollment in Pivotal Phase 3 Study of EBI-005 in Patients with Dry Eye Disease investment picks
Eleven Biotherapeutics, Inc. (Nasdaq: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced the issuance of U.S. Patent No.
Sign-up for Eleven Biotherapeutics Granted U.S. Composition-of-Matter Patent for EBI-005 investment picks
Eleven Biotherapeutics (NASDAQ: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today reported financial results for the third quarter ended September 30, 2014 and recent business highlights.
Sign-up for Eleven Biotherapeutics Reports Third Quarter 2014 Financial Results investment picks
Eleven Biotherapeutics (NASDAQ: EBIO), a biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced that Abbie Celniker, Ph.D., President and Chief Executive Officer, will participate in the following upcoming investor conferences in September: A live webcast of the NewsMakers in the Biotech Industry Conference can be accessed from the Investors & Media section of Eleven’s website at www.elevenbio.com .
Sign-up for Eleven Biotherapeutics to Participate in Upcoming Investor Conferences in September investment picks
Eleven Biotherapeutics (NASDAQ: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced it will report third quarter 2014 financial results on Thursday, November 13, 2014.
Sign-up for Eleven Biotherapeutics to Report Third Quarter 2014 Financial Results on November 13, 2014 investment picks
Elgin Mining Shareholders Overwhelmingly Approve Plan of Arrangement with Mandalay Resources Canada NewsWire TORONTO , Sept.
Sign-up for Elgin Mining Shareholders Overwhelmingly Approve Plan of Arrangement with Mandalay Resources investment picks
Eli Lilly (LLY) said it would pay U.K. drug maker AstraZeneca (AZN) up to $500 million in development and regulatory milestone payments, as part of a new agreement to co-develop and commercialize AstraZeneca's Alzheimer's treatment.
Sign-up for Eli Lilly agrees to co-develop AstraZeneca's Alzheimer's treatment investment picks
Drug maker Eli Lilly & Co.
Sign-up for Eli Lilly profit sinks 58%, revenue declines investment picks
NEW YORK , Sept.
Sign-up for Elisabeth DeMarse Named To Folio:'s Inaugural List Of Top Women In Media investment picks
2014/10/30
Some of the largest registered investment advisors (“RIAs”) not only expect industry consolidation to accelerate in the coming year, many plan to contribute to this trend directly by making an acquisition, according to a survey conducted by TD Ameritrade Institutional 1 during its 2014 Elite Summit.
Sign-up for Elite Advisors Say Scalability, Succession Needs Will Fuel More RIA Deal Activity investment picks
NORTHVALE, N.J., Oct.
Sign-up for Elite Pharmaceuticals Announces New Management Appointments investment picks
Revenues Increase by 61%, Product Development on Schedule NORTHVALE, N.J., Aug.
Sign-up for Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2015 investment picks
Revenues increase by 8% NORTHVALE, N.J., Nov.
Sign-up for Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2015 investment picks
NORTHVALE, N.J., Aug.
Sign-up for Elite Pharmaceuticals, Inc. to Host Quarterly Business Update Call on August 18, 2014 investment picks
Wells Fargo & Company (NYSE:WFC) today said that its board of directors has elected Elizabeth A.
Sign-up for Elizabeth A. Duke Elected to the Board of Wells Fargo & Company investment picks
Elizabeth Arden, Inc. (NASDAQ:RDEN), a global prestige beauty products company, today announced that Nightingale Onshore Holdings L.P. and Nightingale Offshore Holdings L.P., investment funds affiliated with Rhône Capital L.L.C. (referred to together as “Rhône Capital”), have commenced a partial tender offer to acquire up to 6,442,013 shares of the Company’s outstanding common stock, constituting approximately 20% of such outstanding common stock (including shares of common stock underlying warrants held by Rhône Capital), at a cash purchase price of $17.00 per share (the “Offer”). The commencement of the Offer is consistent with Rhône Capital’s previously announced intention to increase their investment in the Company following Rhône Capital’s purchase of 50,000 shares of the Company’s Series A Serial Preferred Stock and warrants to purchase 2,452,267 shares of the Company’s common
Sign-up for Elizabeth Arden Announces Intent to Evaluate Tender Offer by Affiliates of Rhône Capital investment picks
Elizabeth Arden, Inc. (NASDAQ:RDEN), a global prestige beauty products company, today announced financial results for its first fiscal quarter ended September 30, 2014.
Sign-up for Elizabeth Arden, Inc. Announces First Quarter Fiscal 2015 Results investment picks
2014/11/4
By Isabella Zhong The MSCI Asia Index has experienced plenty of ups and downs but is flat this year.
Sign-up for Elke Schoeppl-Jost Sees 4 Markets to Focus On -- Barron's Asia investment picks
2014/11/3
By Isabella Zhong The MSCI Asia Index has experienced plenty of ups and downs but is flat this year.
Sign-up for Elke Schoeppl-Jost Sees 4 Markets to Focus On -- Barron's Asia investment picks
2014/10/15
WEST CHESTER, Pa.
Sign-up for Ellen DeGeneres Launches Seasonal Home Collection With QVC investment picks
Campbell Soup Company (NYSE:CPB) today announced that Ellen Oran Kaden, Senior Vice President – Chief Legal and Public Affairs Officer, has informed the company of her decision to retire from Campbell on May 1, 2015.
Sign-up for Ellen Oran Kaden to Retire from Campbell on May 1, 2015 investment picks
Ellie Mae® (NYSE:ELLI), a leading provider of innovative on-demand software solutions and services for the residential mortgage industry, announced that it has recently surpassed 100,000 active users of its Encompass® mortgage management solution , the mortgage industry’s solution for achieving compliance, loan quality and efficiency.
Sign-up for Ellie Mae Achieves Major Milestone with 100,000 Active Encompass Users investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Elephant Talk Reports Third Quarter Financial Results to Ellie Mae Achieves Major Milestone with 100,000 Active Encompass Users
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent